Copyright
©The Author(s) 2015.
World J Exp Med. May 20, 2015; 5(2): 64-76
Published online May 20, 2015. doi: 10.5493/wjem.v5.i2.64
Published online May 20, 2015. doi: 10.5493/wjem.v5.i2.64
Table 1 Nitric oxide in immune cells
| Cell compartment | Features | Ref. |
| Innate immunity | ||
| Macrophage | ||
| M1 | High level of NO | [55-59,61] |
| Expression of iNOS | ||
| NO-mediated cytotoxicity | ||
| M2 | Reduced level of NO | |
| Immune suppressive function | ||
| Natural Killer cells | ||
| NO-mediated cytotoxicity | [84,85] | |
| NO-mediated cell fitness | ||
| Mast cells | ||
| NOS expression | [87,89-91,93] | |
| NO-mediated cell adhesion and function | ||
| Myeloid-derived suppressor cell | ||
| iNOS expression | [62,64,94,95] | |
| Immune modulating function | ||
| Dendritic cells | ||
| NOS expression | [72,73,75-77] | |
| Pathogen clearance | ||
| Adaptive immunity | ||
| Lymphocyte | ||
| T-cell | T-cell activation and function | [64-68,72,73] |
| T-cell commitment | ||
| B-cell | Reduced level of NO | [69] |
| T-independent antibody response | ||
Table 2 Nitric oxide and its effect in pathologies
| Disease | Pathogenesis | Ref. |
| Autoimmune diseases | ||
| Appearance of neo-epitopes | [29,30,96-98,101,123, 126,130] | |
| Disruption of physical barriers | ||
| Amelioration of pathological status | ||
| Metabolic disease | ||
| Deregulated accumulation of proteins or their abnormal modification | [109,110,115,119,120] | |
| Cancer | ||
| Establishment of an immune suppressive environment | [140-142,147,151,152, 155,157,160] | |
| Alteration in DNA repair mechanisms | ||
- Citation: Predonzani A, Calì B, Agnellini AH, Molon B. Spotlights on immunological effects of reactive nitrogen species: When inflammation says nitric oxide. World J Exp Med 2015; 5(2): 64-76
- URL: https://www.wjgnet.com/2220-315X/full/v5/i2/64.htm
- DOI: https://dx.doi.org/10.5493/wjem.v5.i2.64
